Percutaneous endovascular management of occluded HeRO dialysis access device.
The Hemodialysis Reliable Outflow (HeRO) device is a novel alternative for dialysis access in patients with no suitable veins in the upper extremities. We placed a HeRO device in a 67-year-old woman with end-stage renal disease and 2 months later, it was being used for hemodialysis. After 1 month of uneventful use, the device thrombosed and it was rescued with a percutaneous endovascular approach. The device remains patent 6 months after the intervention.
Vasquez
Julio C
JC
Portneuf Medical Center and Idaho State University, Pocatello, Idaho 83201, USA. juvasquez@yahoo.com
DeLaRosa
Jacob
J
Leon
Juan J
JJ
Rahim
Naeem
N
Rahim
Fahim
F
D000368:Aged; D000714:Anastomosis, Surgical; D000800:Angioplasty, Balloon / Q000295:instrumentation*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation*; D001916:Brachial Artery / Q000601:surgery; D003251:Constriction, Pathologic; D004867:Equipment Design; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007601:Jugular Veins / Q000601:surgery; D007676:Kidney Failure, Chronic / Q000628:therapy; D011138:Polytetrafluoroethylene; D011474:Prosthesis Design; D011475:Prosthesis Failure; D011859:Radiography; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation*; D015607:Stents; D017131:Thrombectomy; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D016896:Treatment Outcome; D014654:Vascular Patency
D005343:Fibrinolytic Agents; D011138:Polytetrafluoroethylene; D010959:Tissue Plasminogen Activator